SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,024,740 | -33.0% | 49,793 | +24.1% | 0.01% | -50.0% |
| Q4 2022 | $1,528,818 | +15.2% | 40,137 | +30.9% | 0.02% | +46.7% |
| Q4 2021 | $1,327,000 | -2.3% | 30,671 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $1,358,000 | -45.9% | 30,671 | -30.7% | 0.02% | -42.3% |
| Q2 2021 | $2,512,000 | +317.3% | 44,271 | +450.5% | 0.03% | +333.3% |
| Q1 2021 | $602,000 | -13.5% | 8,042 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $696,000 | – | 8,042 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |